Joshua C. Vaughan

Joshua C. Vaughan

Auto-generated profile, based on publicly available information

Joshua C. Vaughan

Department of Chemistry, University of Washington, Seattle, WA 98195

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2016 in Nature Methods
Verified
Journal Article
Closed access
PDF file
TCTyler J Chozinski
Tyler J Chozinski
AHAaron R Halpern
Aaron R Halpern
HOHaruhisa Okawa
Haruhisa Okawa
HKHyeon-Jin Kim
Hyeon-Jin Kim
GTGrant J Tremel
Grant J Tremel
JVJoshua C Vaughan
Joshua C Vaughan

17 September 2018 in Chemical Reviews
Verified
Journal Article
Closed access
HLHonglin Li
Honglin Li
JVJoshua C. Vaughan
Joshua C. Vaughan

22 November 2017 in ACS Nano
Verified
Journal Article
Closed access
AHAaron R. Halpern
Aaron R. Halpern
GAGermain C. M. Alas
Germain C. M. Alas
TCTyler J. Chozinski
Tyler J. Chozinski
APAlexander Paredez
Alexander Paredez
JVJoshua C. Vaughan
Joshua C. Vaughan

7 July 2014 in FEBS Letters
Verified
Journal Article
Closed access
TCTyler J. Chozinski
Tyler J. Chozinski
LGLauren A. Gagnon
Lauren A. Gagnon
JVJoshua C. Vaughan
Joshua C. Vaughan

29 May 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
CMChenyi Mao
Chenyi Mao
MLMin Yen Lee
Min Yen Lee
JJJing-Ru Jhan
Jing-Ru Jhan
AHAaron R. Halpern
Aaron R. Halpern
MWMarcus A. Woodworth
Marcus A. Woodworth
JVJoshua C. Vaughan
Joshua C. Vaughan
FLARE enables rapid, feature-rich stains of chemical groups in biological samples for super-resolution and cleared tissue imaging.

15 August 2022 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JPJeffrey W. Pippin
Jeffrey W. Pippin
NKNatalya Kaverina
Natalya Kaverina
YWYuliang Wang
Yuliang Wang
DEDiana G. Eng
Diana G. Eng
YZYuting Zeng
Yuting Zeng
SSStuart J. Shankland
Stuart J. Shankland
With an aging population, kidney health becomes an important medical and socioeconomic factor. Kidney aging mechanisms are not well understood. We previously showed that podocytes isolated from aged mice exhibit increased expression of programmed cell death protein 1 (PD-1) surface receptor and its 2 ligands (PD-L1 and PD-L2). PDCD1 transcript increased with age in microdissected human glomeruli, which correlated with lower estimated glomerular filtration rate and higher segmental glomerulosclerosis and vascular arterial intima-to-lumen ratio. In vitro studies in podocytes demonstrated a critical role for PD-1 signaling in cell survival and in the induction of a senescence-associated secretory phenotype. To prove PD-1 signaling was critical to podocyte aging, aged mice were injected with anti–PD-1 antibody. Treatment significantly improved the aging phenotype in both kidney and liver. In the glomerulus, it increased the life span of podocytes, but not that of parietal epithelial, mesangial, or endothelial cells. Transcriptomic and immunohistochemistry studies demonstrated that anti–PD-1 antibody treatment improved the health span of podocytes. Administering the same anti–PD-1 antibody to young mice with experimental focal segmental glomerulosclerosis (FSGS) lowered proteinuria and improved podocyte number. These results suggest a critical contribution of increased PD-1 signaling toward both kidney and liver aging and in FSGS.